Pura Vida Investments, LLC Gh Research PLC Transaction History

Pura Vida Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$6.02 - $10.92 $802,628 - $1.46 Million	-133,327 Reduced 84.21%	25,000 $199,000
Q3 2022 Nov 14, 2022	SELL	$10.15 - $16.15 $509,530 - $810,729	-50,200 Reduced 24.07%	158,327 $1.84 Million
Q1 2022 May 16, 2022	SELL	$15.48 - $23.98 $292,572 - $453,222	-18,900 Reduced 8.31%	208,527 $3.81 Million
Q4 2021 Feb 14, 2022	SELL	$14.1 - $27.9 $2.15 Million - $4.26 Million	-152,618 Reduced 40.16%	227,427 $5.31 Million
Q3 2021 Nov 15, 2021	SELL	$16.51 - $23.68 $329,457 - $472,534	-19,955 Reduced 4.99%	380,045 $8.38 Million
Q2 2021 Aug 16, 2021	BUY	$19.25 - $21.73 $7.7 Million - $8.69 Million	400,000 New	400,000 $8.69 Million

23.5M

63.1K

1.9K

Ticker GHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,020,800
Market Cap $433M
Description
GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.